The totally implantable venous access device (TIVAD), also known as venous infusion port, is an emerging intravenous access device primarily used for chemotherapy and parenteral nutrition support. Its reliability and effectiveness have been confirmed by recent applications. Currently, the utilization of this technology in domestic settings is mainly concentrated in large medical institutions. However, there are significant differences in implantation surgery and maintenance practices among different regions, resulting in variations in actual outcomes, high incidence of related complications, and differences in patient satisfaction. The expert group, consisting of experienced professionals from various disciplines involved in TIVAD work, has collaborated and extensively discussed the latest research findings and then developed the Multidisciplinary expert consensus on implantation and management of venous infusion port (2023 edition). This consensus applies to healthcare professionals engaged in TIVAD work and covers the entire process of implantation and maintenance of the venous infusion port. The goal is to reduce complications associated with implantation and usage and improve the safety and satisfaction of patients using a TIVAD.